Meeting
2022 ASCO Annual Meeting
Artificial intelligence algorithms for the diagnosis of urothelial carcinoma based on urine cytology: A noninvasive and efficient diagnostic approach.
Authors
Chong Shen
The second hospital of Tianjin Medical University, Tianjin, China
Chong Shen , HaiTao Wang Sr., Hailong Hu , Yuanjie Niu , Dawei Tian , Shiwang Huang , Gangjian Zhao , Chuanyi Huang , Zhouliang Wu , Zhe Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Urothelial Cancer - Local-Regional Disease
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4590)
DOI
10.1200/JCO.2022.40.16_suppl.4590
Abstract #
4590
Poster Bd #
81
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2024 ASCO Genitourinary Cancers Symposium
i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for prostate cancer.
First Author: Alexandru George Floares
Poster
2023 ASCO Breakthrough
i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for breast cancer.
First Author: Alexandru George Floares
Poster
2023 ASCO Breakthrough
LookUpTrials: Assessment of an artificial intelligence-powered mobile application to engage oncology providers in clinical trials.
First Author: Kin Wai (Tony) Hung